Close Bookmark and Share This Page

Save to Browser Favorites / Bookmarks

Ask backflip blinklist BlogBookmark Bloglines BlogMarks Blogsvine BuddyMarks BUMPzee! CiteULike Connotea del.icio.us

Digg diigo DotNetKicks DropJack dzone Facebook Fark Faves Friendsite folkd.com Furl Google

Jamespot Jeqq Kaboodle kirtsy linkaGoGo LinkedIn Ma.gnolia Mister Wong Mixx MySpace Netvouz Newsvine

oneview OnlyWire PlugIM Propeller Reddit Segnalo Shoutwire Simpy Slashdot Surphace Sphinn Spurl

Squidoo StumbleUpon Technorati ThisNext Twitter Webride Windows Live Yahoo!

Email This to a Friend

  Link HTML: 

 Permalink: 

 If you like this then please subscribe to the RSS Feed.

Powered by Bookmarkify™

More »

Major pharmaceutical companies aren’t usually quick to form partnerships with small biotechs, unless the big guys see a promise of getting their hands on attractive new drug candidates. Well, little-known biopharmaceutical outfit Micromet (MITI) has attracted not just one but seven Big Pharmas that have signed partnership pacts to help develop some of its products. Micromet’s No. 1 appeal: It’s developing novel antibody-based drugs to treat cancer, inflammatory and autoimmune diseases.

Read the complete article here.

Happy trading,

Curt